Fair Value Measurement Text (Details) $ in Millions	12 Months Ended
	Dec. 31, 2020 USD ($)
Hospira [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
contingent consideration gross	$ 225.0
Pursuit Vascular, Inc. [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
contingent consideration gross	$ 50.0